Search Results - N. V. Furman

Refine Results
  1. 1

    CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION by N. V. Furman, S. S. Shmatova

    Published 2015-09-01

    Interval QT prolongation is a predictor of the life-threatening cardiac arrhythmias — polymorphic ventricular tachycardia (torsade de pointes). Long QT syndrome may be congenital or acquired. It is known that a wide range of both antiarrhythmic and non-cardiac medications might lead to QT interval p...

    Full description

    Get full text
    Article
  2. 2

    QT and QTa interval duration and dispersion during stress test in coronary heart disease and ventricular arrhythmia patients by N. V. Furman, S. S. Shmatova, P. Ya. Dovgalevsky

    Published 1970-01-01

    Aim. То investigate the link between dynamics of QT and QTa duration and dispersion, corrected QT and QTa (QTc, QTac) in coronary heart disease (CHD) patients undergoing treadmill stress test, with ventricular arrhythmia registration. Material and metliods. In total, 77 patients with Functional Clas...

    Full description

    Get full text
    Article
  3. 3

    Diagnosing hemodynamically important coronary atherosclerosis in stable angina patients: the role of stress test dynamics of QT duration and dispersion by N. V. Furman, P. Ya. Dovgalevsky, S. S. Shmatova

    Published 2008-06-01

    Aim. To study a potential link between increased QT dispersion (dQT) during physical stress test (PST) and coronary artery (CA) atherosclerosis in patients with coronary heart disease (CHD).Material and methods. In total, 116 CHD patients with Functional Class II-III angina were examined (mean age 4...

    Full description

    Get full text
    Article
  4. 4

    A CASE OF PAINLESS MYOCARDIAL INFARCTION DUE TO BRIDGING OF LEFT ANTERIOR DESCENDING ARTERY by O. S. Bogomolova, N. V. Furman, I. V. Titkov

    Published 2014-07-01

    Myocardial bridging (MB) is congenital abnormality of the coronary arteries, which typically does not interfere with long term prognosis, but in some cases can cause myocardial infarction and other life-threatening conditions. This article reviews current knowledge about the anatomy, pathophysiology...

    Full description

    Get full text
    Article
  5. 5

    ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME by O. V. Reshetko, R. M. Magdeev, N. V. Furman

    Published 2015-12-01

    Aim. To evaluate the pre-hospital treatment of patients with acute coronary syndromes (acute myocardial infarction and unstable angina) in 2001 and 2006.Material and methods. Retrospective pre-hospital treatment survey was performed in 1114 patients with acute coronary syndrome (acute myocardial inf...

    Full description

    Get full text
    Article
  6. 6
  7. 7

    THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY by O. V. Reshetko, N. V. Furman, R. M. Magdeev

    Published 2016-01-01

    Aim. To evaluate the structure of drug prescriptions in acute coronary syndrome (acute myocardial infarction and unstable angina) on the first day of hospital therapy in Saratov city and Saratov region.Material and methods. Retrospective pharmacoepidemiology study was carried out in 1276 patients wi...

    Full description

    Get full text
    Article
  8. 8

    PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION by N. V. Mikheeva, O. V. Reshetko, N. V. Furman

    Published 2015-09-01

    Aim. To analyze pharmacotherapy of cerebral infarction in patients with atrial fibrillation (AF) in real clinical practice of neurological departments of Saratov hospitals.Material and methods. A retrospective longitudinal pharmacoepidemiologic study was carried out. Medical cards were analyzed in p...

    Full description

    Get full text
    Article
  9. 9

    RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA by N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi

    Published 2015-12-01

    Aim. To estimate the prevalence of atherothrombotic complications depending on platelet sensitivity to acetylsalicylic acids (ASA) in patients with stable angina.Material and methods. 96 patients with stable angina of II-III functional classes received basic therapy included ASA (125 mg daily) to pr...

    Full description

    Get full text
    Article
  10. 10

    CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES by P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian

    Published 2016-01-01

    Atherothrombosis is a complication of ischemic heart disease, and it leads to development of acute coronary syndrome. Atherothrombosis is characterized by sudden destruction of atherosclerotic plaque, which results into platelets activation and thrombus formation. Aspirin - one of the most widely us...

    Full description

    Get full text
    Article
  11. 11

    PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE by I. V. Graifer, O. V. Reshet'ko, N. V. Furman

    Published 2016-01-01

    Aim. To analyze current clinical practice in the treatment of atrial fibrillation (AF) in emergency care department of multidisciplinary hospital in 2008-2009. Material and methods. Retrospective continuous pharmacoepidemiology study was carried out. Hospital history sheets of the patients admitted...

    Full description

    Get full text
    Article
  12. 12

    UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION by E. A. Protasova, N. V. Furman, O. V. Reshet'ko

    Published 2015-12-01

    Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of exp...

    Full description

    Get full text
    Article
  13. 13

    COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL... by L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky

    Published 2015-09-01

    Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods. An open non-randomized study was conducted to evaluate direct medical costs (cost of drug, cost of the...

    Full description

    Get full text
    Article
  14. 14

    RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID by N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky

    Published 2016-01-01

    Aim. To evaluate risk of repeated atherothrombotic events in patients survived acute coronary syndrome (ACS) and having poorly reduced platelet aggregation (proven by optical aggregometry) in response to acetylsalicylic acid (ASA) therapy.Material and methods. 200 patients with ACS (aged 56,6±9,2 y....

    Full description

    Get full text
    Article
  15. 15

    MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya

    Published 2017-03-01

    Monitoring of the effectiveness of drug therapy is one of the most debated issues in everyday clinical practice. The emergence of new drugs,  methods of analysis, standards, management protocols, and clinical guidelines increases the information load on practitioners and requires a significant inves...

    Full description

    Get full text
    Article
  16. 16

    High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in p... by N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova

    Published 2016-09-01

    Aim. To study the prevalence of high residual platelet reactivity (HRPR) during the dual antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients with ischemic heart disease (IHD) after percutaneous transluminal coronary angioplasty (PTCA) in cli...

    Full description

    Get full text
    Article
  17. 17

    COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 by O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman

    Published 2018-03-01

    Aim. To compare features of pharmacotherapy of patients with chronic heart failure (CHF) with a reduced ejection fraction of the left ventricle (LV EF) who were admitted in a specialized department of the multidisciplinary hospital in Saratov before and after the publication of the Russian National...

    Full description

    Get full text
    Article
  18. 18

    INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK by N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky

    Published 2016-01-01

    Estimation of cardiovascular risk is discussed. Serum lipoproteins, glucose, fibrinogen, von Willebrand factor, tissue-type plasminogen activator, C-reactive protein etc are offered for use as laboratory indicators. At the same time new markers of high cardiovascular risk are under development. D-di...

    Full description

    Get full text
    Article
  19. 19

    Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) by O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov

    Published 2020-11-01

    Aim. To study the changes that have occurred in the pharmacotherapy of atrial fibrillation (AF) in the Saratov Region for 5 years by analyzing the antithrombotic therapy of patients who were admitted in a specialized department of the multidisciplinary hospital in Saratov in 2011-2012 and in 2016-20...

    Full description

    Get full text
    Article
  20. 20

    PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE by P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko

    Published 2015-09-01

    Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real clinical practice. Material and methods. A continuous pharmacoepidemiological analysis was performed on the base of 153 records of patients with...

    Full description

    Get full text
    Article